248 related articles for article (PubMed ID: 20726676)
1. Results of a safety initiative for patients on concomitant amiodarone and simvastatin therapy in a Veterans Affairs medical center.
Karimi S; Hough A; Beckey C; Parra D
J Manag Care Pharm; 2010 Sep; 16(7):472-81. PubMed ID: 20726676
[TBL] [Abstract][Full Text] [Related]
2. Effect of simvastatin-amiodarone drug interaction alert on appropriate prescribing.
Prom R; Umscheid CA; Kasbekar N; Spinler SA
Am J Health Syst Pharm; 2013 Nov; 70(21):1878-9. PubMed ID: 24128959
[No Abstract] [Full Text] [Related]
3. Rhabdomyolysis in association with simvastatin and amiodarone.
Roten L; Schoenenberger RA; Krähenbühl S; Schlienger RG
Ann Pharmacother; 2004 Jun; 38(6):978-81. PubMed ID: 15069169
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database.
Tuchscherer RM; Nair K; Ghushchyan V; Saseen JJ
Am J Cardiovasc Drugs; 2015 Feb; 15(1):27-34. PubMed ID: 25348907
[TBL] [Abstract][Full Text] [Related]
5. Concurrent use of statins and amiodarone.
Borders-Hemphill V
Consult Pharm; 2009 May; 24(5):372-9. PubMed ID: 19555146
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a pharmacist-managed amiodarone monitoring program.
Spence MM; Polzin JK; Weisberger CL; Martin JP; Rho JP; Willick GH
J Manag Care Pharm; 2011 Sep; 17(7):513-22. PubMed ID: 21870892
[TBL] [Abstract][Full Text] [Related]
7. Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy.
Foody JM; Toth PP; Tomassini JE; Sajjan S; Ramey DR; Neff D; Tershakovec AM; Hu H; Tunceli K
Vasc Health Risk Manag; 2013; 9():719-27. PubMed ID: 24265554
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice.
Heintjes EM; Penning-van Beest FJ; Plat AW; Meerding WJ; Webb K; Sturkenboom MC; Herings RM
Pharmacotherapy; 2012 Jul; 32(7):631-41. PubMed ID: 22760692
[TBL] [Abstract][Full Text] [Related]
9. Low vitamin D as a risk factor for the development of myalgia in patients taking high-dose simvastatin: a retrospective review.
Mergenhagen K; Ott M; Heckman K; Rubin LM; Kellick K
Clin Ther; 2014 May; 36(5):770-7. PubMed ID: 24742497
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
11. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin, amiodarone, and atazanavir.
Schmidt GA; Hoehns JD; Purcell JL; Friedman RL; Elhawi Y
J Am Board Fam Med; 2007; 20(4):411-6. PubMed ID: 17615423
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.
Milner E; Ainsworth M; Gleaton M; Bookstaver D
J Clin Pharm Ther; 2022 May; 47(5):668-675. PubMed ID: 35032137
[TBL] [Abstract][Full Text] [Related]
13. Concomitant use of simvastatin and amiodarone resulting in severe rhabdomyolysis: a case report and review of the literature.
Marot A; Morelle J; Chouinard VA; Jadoul M; Lambert M; Demoulin N
Acta Clin Belg; 2011; 66(2):134-6. PubMed ID: 21630612
[TBL] [Abstract][Full Text] [Related]
14. Adherence to drug label recommendations for avoiding drug interactions causing statin-induced myopathy--a nationwide register study.
Settergren J; Eiermann B; Mannheimer B
PLoS One; 2013; 8(8):e69545. PubMed ID: 23940522
[TBL] [Abstract][Full Text] [Related]
15. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
[TBL] [Abstract][Full Text] [Related]
16. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions.
Alford JC; Saseen JJ; Allen RR; Nair KV
Pharmacotherapy; 2012 Jul; 32(7):623-30. PubMed ID: 22570173
[TBL] [Abstract][Full Text] [Related]
17. Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liability.
Golightly LK; Barber GR; Barron MA; Page RL
Drug Metabol Drug Interact; 2013; 28(1):49-58. PubMed ID: 23314530
[TBL] [Abstract][Full Text] [Related]
18. Adverse events with concomitant amiodarone and statin therapy.
Alsheikh-Ali AA; Karas RH
Prev Cardiol; 2005; 8(2):95-7. PubMed ID: 15860984
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
